Cited by 33Menopause: Health Impacts and TreatmentsNeural and Behavioral Psychology StudiesNeurotransmitter Receptor Influence on Behavior

Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function Difficulties

Open access
Shanmugan, Sheila, Loughead, James, Nanga, Ravi Prakash Reddy, Elliott, Mark, Hariharan, Hari, Appleby, Dina, Kim, Deborah, Ruparel, Kosha +3 more·2017·Neuropsychopharmacology

Abstract

Many women with no history of executive dysfunction report difficulties in this domain during the menopause transition. Lisdexamfetamine (LDX) has been suggested to be a safe and effective treatment option for these women. However, the mechanism by which LDX improves executive functioning in these women is not known. Here we investigated the effects of LDX on brain activation and neurochemistry, hypothesizing that LDX would be associated with increased activation and decreased glutamate in executive regions. Fourteen women underwent multimodal neuroimaging at 7T at three time points in this baseline-corrected, double-blind, placebo-controlled, crossover study. Effects of LDX on symptom severity, blood-oxygen-level-dependent (BOLD) signal, and dorsolateral prefrontal cortex (DLPFC) glutamate+glutamine (Glx) were measured using a clinician-administered questionnaire, fMRI during performance of a fractal n-back task, and 1 H-MRS, respectively. The effect of treatment (LDX minus baseline vs placebo minus baseline) on these behavioral and neural markers of executive function was examined using repeated measures mixed effects models. LDX treatment was associated with decreased symptom severity, increased activation in the insula and DLPFC, and decreased DLPFC Glx. In addition, the magnitude of LDX-induced improvement in symptom severity predicted both direction and magnitude of LDX-induced change in insular and DLPFC activation. Moreover, symptom severity was positively correlated with Glx concentration in the left DLPFC at baseline. These findings provide novel evidence that the neural mechanisms by which LDX acts to improve self-reported executive functioning in healthy menopausal women with midlife onset of executive difficulties include modulation of insular and DLPFC recruitment as well as decrease in DLPFC Glx concentration.

Integrity signals

Registry

Crossref · 10.1038/npp.2016.162

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shanmugan, S., Loughead, J., Nanga, R. P. R., Elliott, M., Hariharan, H., Appleby, D., Kim, D., Ruparel, K., Reddy, R., Brown, T. E., & Epperson, C. N.
Affiliations
  • University of Pennsylvania (US)
  • Yale University (US)
Corresponding author
Epperson, C Neill
Venue
Neuropsychopharmacology
Published
2016-08-23
Volume
42
Issue
2
Pages
437-445
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2507664632
Cited by
33
References
37
Citations by year
2026: 4 · 2025: 3 · 2024: 5 · 2023: 4 · 2022: 2 · 2021: 1 · 2020: 5 · 2019: 2 · 2018: 4 · 2017: 3
FWCI
3.01
Type
journal article
Language
en
Open access
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Shire
  • National Institute of Biomedical Imaging and Bioengineering (P41EB015893)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
lisdexamfetamine, menopause, executive function, executive dysfunction, menopausal women, dorsolateral prefrontal cortex, insula, glutamate, glutamine, brain activation, neurochemistry, symptom severity
MeSH terms
Lisdexamfetamine Dimesylate, Central Nervous System Stimulants, Double-Blind Method, Female, Glutamine, Humans, Memory, Short-Term, Menopause, Middle Aged, Prefrontal Cortex, Cross-Over Studies, Glutamic Acid, Executive Function

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review